HLA-B Associates With Distinct Disease Expression in Juvenile Spondyloarthritis: A Retrospective Cohort Study.

Authors

Dimitrios V Bikas, Timothy G Brandon, Brittney N Newby, Pamela F Weiss

Published in

ACR open rheumatology. Volume 8. Issue 8. Pages e90122.

Abstract

This study aimed to investigate for possible association between HLA-B genotype and disease phenotype in children with juvenile spondyloarthritis (JSpA).
This was a cross-sectional retrospective study of children evaluated at a large tertiary care rheumatology clinic. Inclusion criteria were (1) fulfillment of criteria for juvenile idiopathic arthritis (JIA) subtypes: enthesitis-related arthritis (ERA), psoriatic arthritis (PsA), or undifferentiated JIA (ERA criteria plus a first-degree relative with psoriasis); or (2) a diagnosis of inflammatory bowel disease-associated arthritis (IBD-AA); or (3) magnetic resonance imaging-confirmed inflammatory sacroiliitis in patients who did not meet JIA subtype criteria. All children underwent complete HLA-B testing. Comparisons of HLA-B allele frequencies between JSpA and a published national cohort were conducted through two-sample tests of proportions and controlled for multiple testing using the Benjamini-Hochberg procedure.
There were 150 children who met the inclusion criteria, and 28% (42 of 150) were HLA-B*27-positive. Overall, participants exhibited pronounced heterogeneity in phenotypic and allelic composition, with HLA-B variants associated with distinct patterns of disease expression. Overall, HLA-B*35:02 was significantly enriched in children with IBD-AA (P = 0.007) and in the overall occurrence of IBD (P = 0.005), whereas HLA-B*57:01 was significantly enriched in children with PsA (P = 0.006).
These patterns suggest a key role for HLA-B variants in disease pathogenesis, possibly driving diverse JSpA expression through distinct immunogenetic dysregulation. Our findings underscore the need to further elucidate the biologic connection between HLA-B and JSpA, with potential insights that may inform clinical care and guide future investigation.

PMID:
42610327
Bibliographic data and abstract were imported from PubMed on 18 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.